Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
Is Vaxart a Buy?
06:03am, Wednesday, 12'th May 2021
Can this troubled coronavirus vaccine developer redeem itself and its investors?
Vaxart's No-Shot Vaccine Is a Potential Game Changer
01:48pm, Tuesday, 11'th May 2021
VXRT stock is down from its highs, but there's no need to worry, as Vaxart has a unique Covid-19 vaccine and some encouraging clinical data. The post Vaxart's No-Shot Vaccine Is a Potential Game Chang
Is Vaccine Maker Vaxart Worth Holding From Here?
02:14pm, Sunday, 09'th May 2021
As with most investment decisions, whether to hold depends on the situation. Here are some things to think about.
Better Vaccine Stock: Ocugen or Vaxart?
06:10am, Friday, 07'th May 2021
Here's how the biotechs compare on several key fronts.
Vaxart's Vaccine Candidate Is a Pill, Not a Shot. Does It Matter?
06:35am, Thursday, 06'th May 2021
If it can reach the market of people that are hesitant to be vaccinated, yes.
Why Vaxart Stock Is Surging Today
04:07pm, Tuesday, 04'th May 2021
Investors are excited about the company's experimental COVID-19 vaccine.
Vaxart Stock Surges on Oral Covid-19 Vaccine Update
10:18am, Tuesday, 04'th May 2021
The shares of biotechnology concern Vaxart Inc (NASDAQ:VXRT) are up a whopping 11.5% to trade at $8.94 at last check , after the company announced its oral coronavirus vaccine produced positive ph
Why Vaxart Shares Popped 78% in April
09:57am, Tuesday, 04'th May 2021
Shareholders keep getting their hopes up for the company's tablet-based COVID-19 vaccine.
Vaxart Stock Is Surging As Its Oral COVID-19 Vaccine Can Potentially Trigger Immunity Against Variants
07:01am, Tuesday, 04'th May 2021
Vaxart Inc (NASDAQ: VXRT) has announced new data from the Phase 1 trial evaluating its oral COVID-19 vaccine candidate, dubbed as VXA-CoV2-1. Data obtained showed substantial CD8+ T-cell responses
VXRT Stock: From $8.02 To $9.48 (18.2% Increase) Pre-Market Explanation
06:46am, Tuesday, 04'th May 2021
The stock price of Vaxart Inc (NASDAQ: VXRT) increased from $8.02 to $9.48 (up 18.2%) pre-market. This is why it happened.
New Data from Vaxart Oral COVID-19 Vaccine Phase I Study Suggests Broad Cross-Reactivity against Other Coronaviruses
05:06pm, Monday, 03'rd May 2021
Vaxart oral vaccine induced higher CD8 + T-Cell responses than those seen with Moderna or Pfizer vaccines in comparative experiment conducted by the Company
VAXART, INC. (VXRT) Reports Q1 Loss, Misses Revenue Estimates
10:31am, Monday, 03'rd May 2021
VAXART, INC. (VXRT) delivered earnings and revenue surprises of -40.00% and -17.99%, respectively, for the quarter ended March 2021.
VXRT Stock: From $10.78 To Over $12.15 Pre-Market
04:25am, Monday, 03'rd May 2021
The stock price of Vaxart Inc (NASDAQ: VXRT) increased from $10.78 to over $12.15 during pre-market trading as of 4:07 AM ET today. This is why it happened.
Why Vaxart Stock Is Soaring Today
06:17pm, Friday, 30'th Apr 2021
The biotech is slated to provide updates to investors on its vaccine development efforts next week.
VXRT Stock: From $8.44 To $11 Explanation
01:51pm, Thursday, 29'th Apr 2021
The stock price of Vaxart Inc (NASDAQ: VXRT) went from a previous close of $8.44 to a day high of $11 today. This is why it happened.
